Immune to Cancer: The CRI Blog
-
Meet Tecla: 50-Mile Rider in the 2017 Answer to Cancer
For Tecla Palli-Sandler, participating in the 2017 Answer to Cancer Cycling Event and 5K Family…
-
New Biomarker ‘Bim’ Could Enable Smarter Treatment for Melanoma Patients
Over the past few years, checkpoint blockade immunotherapies have revolutionized cancer treatment and helped many patients who…
-
Third Immunotherapy Option Approved for Bladder Cancer Patients
On February 2, nivolumab (Opdivo®, Bristol-Myers Squibb) became the newest FDA-approved immunotherapy available for patients with bladder…
-
Immunotherapy Shows Promise Against Previously Untreatable Stomach Cancer
Nivolumab improves survival in patients with advanced stomach cancer.
-
Focused Ultrasound Foundation to Host Free Webinar on Recent Advances in Cancer Immunotherapy
CRI’s CEO and director of scientific affairs will discuss latest research on focused ultrasound and immunotherapy combination…
-
2016: The Year of Cancer Immunotherapy
New immunotherapy approvals, “Advance of the Year” recognition, and the partnerships of the future.
-
Remembering Six-Time Jeopardy! Champion Cindy Stowell
Cindy, who passed from stage 4 colon cancer, has donated her winnings to the Cancer Research Institute.
-
Young Adults “Chasing Cancer”
Guest blogger Ariella Chivil recaps her visit at The Washington Post Chasing Cancer Summit.
-
Immuno-Oncology 360°: Connecting Science & Business to Advance Immunotherapy
The third annual IO360° conferences comes to NYC February 2017.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.